Page last updated: 2024-10-24

candesartan cilexetil and Carcinoma, Lewis Lung

candesartan cilexetil has been researched along with Carcinoma, Lewis Lung in 2 studies

candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects

Carcinoma, Lewis Lung: A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imai, N1
Hashimoto, T1
Kihara, M1
Yoshida, S1
Kawana, I1
Yazawa, T1
Kitamura, H1
Umemura, S1
Fujita, M1
Hayashi, I1
Yamashina, S1
Itoman, M1
Majima, M1

Other Studies

2 other studies available for candesartan cilexetil and Carcinoma, Lewis Lung

ArticleYear
Roles for host and tumor angiotensin II type 1 receptor in tumor growth and tumor-associated angiogenesis.
    Laboratory investigation; a journal of technical methods and pathology, 2007, Volume: 87, Issue:2

    Topics: Adaptor Proteins, Signal Transducing; Analysis of Variance; Animals; Benzimidazoles; Biphenyl Compou

2007
Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis.
    Biochemical and biophysical research communications, 2002, Jun-07, Volume: 294, Issue:2

    Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Antineoplastic Agents; Benzimida

2002